FDA-approved GLP-1 treatments are prescription drugs given by injection or taken orally, not delivered through the skin
Peripheral Metabolic Effects Beyond glucose regulation, GLP2 influences multiple metabolic parameters: Improved insulin sensitivity markers including HOMA2-IR reductions Favorable effects on lipid profiles with reductions in triglycerides and LDL cholesterol Decreased liver enzyme levels suggesting hepatic metabolic improvements Increased insulin-like growth factor binding proteins (IGFBP1 and IGFBP2) [CALLOUT BOX Highlighted] Key Mechanistic Insight: GLP2s imbalanced dual agonism stronger GIP receptor activation combined with biased GLP-1 receptor signaling creates a unique pharmacological profile distinct from selective GLP-1 receptor agonists
If side effects persist, talk to your provider about adjusting your dose or titration schedule in a way that best fits your needs
Fatigue may occur because the body is adjusting to treatment, but it may also reflect under-eating, low protein intake, dehydration, electrolyte changes, rapid weight loss, poor sleep, constipation, low blood sugar, low blood pressure, or another medical issue
In clinical studies, patients using semaglutide for weight loss have seen an average weight reduction of around 10-15% of their body weight over the course of several months
Trulicity may increase the chance of food getting into your lungs during surgery or other procedures